NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-136-2020-0-PCT-03 METHOTREXATE ANALOGS AND METHODS OF USE PCT PCT PCT/US2021/038441 Expired
NCATS E-136-2020-0-EP-05 METHOTREXATE ANALOGS AND METHODS OF USE EP National Stage 21742973.7 Pending
NCATS E-136-2020-0-AU-04 METHOTREXATE ANALOGS AND METHODS OF USE AU National Stage 2021296308 Pending
NCI E-258-2016-0-US-09 CHIMERIC ANTIGEN RECEPTOR (CAR) THAT TARGETS CHEMOKINE RECEPTOR CCR4 AND ITS USE US CON 17/353,054 11992519 Issued PDF
NIAID E-099-2016-0-EP-22 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS EP DIV 21180582.5 Abandoned
NCI E-282-2016-2-IL-01 METHODS OF CONDITIONING PATIENTS FOR T CELL THERAPY IL DIV 284173 Issued
NIDCD E-004-2019-0-US-05 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY US National Stage 17/416,311 Pending
NIAID E-061-2018-0-US-03 EBOLA VIRUS GLYCOPROTEIN-SPECIFIC MONOCLONAL ANTIBODIES AND USES THEREOF US National Stage 17/415,412 Issued
NIAID E-174-2017-1-US-07 Protection Of Calves By A Prefusion-stabillze Bovine RSV Vaccine US CON 17/350,687 Pending
NLM E-107-2010-2-US-34 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 17/350,181 Abandoned
NIDCR E-093-2019-0-PCT-02 SALIVA COLLECTION DEVICE AND METHOD OF USING THE SAME PCT PCT PCT/US2021/037875 Expired
NIAID E-166-2021-3-US-01 Coronavirus Antibodies And Uses Thereof US 63/212,078 Abandoned
NIAID E-130-2020-0-PCT-02 Human IgA Monoclonal Antibody That Targets A Conserved Site On The Plasmodium Falciparum Circumsporozoite Protein PCT PCT PCT/US2021/037571 Expired
NIAID E-216-2021-0-US-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Intravenous Drug Delivery US 63/211,336 Abandoned
NIAID E-052-2017-4-BR-54 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection BR DIV BR122021011713-6 Pending
NCI E-068-2018-0-HK-08 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 HK EP 62021033097.8 Pending
NCI E-244-2015-0-US-12 BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE US DIV 17/346,452 12012438 Issued PDF
NCI E-263-2014-0-US-10 Methods To Eliminate Cancer Stem Cells By Targeting CD47 US CON 17/346,630 Pending
NCI E-175-2016-0-US-16 ANTI-KRAS-G12D T CELL RECEPTORS US CON 17/345,390 11897933 Issued PDF
NHLBI E-122-2021-0-US-01 ALLOSTERIC INHIBITION OF THE LONG ISOFORMS OF PDE4D MITIGATES LIVER FIBROSIS US 63/209,438 Abandoned
NICHD E-141-2019-0-PCT-02 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME PCT PCT PCT/US2021/036809 Expired
NCATS E-229-2020-0-PCT-02 Methods Of Combination Therapy For Treatment Of Mucopolysaccharidosis Type IVA Using Human Recombinant Nacetylgalactosamine
6-sulfatase (hrGALNS) And Pharmacological Chaperones 		PCT PCT PCT/IB2021/055134 Expired
NICHD E-141-2019-0-EP-08 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME EP National Stage 21745474.3 Pending
NCI E-007-2019-0-EP-04 TP5, A PEPTIDE INHIBITOR OF ABERRANT AND HYPERACTIVE CDK5/P25 AS TREATMENT FOR CANCER EP National Stage 19817052.4 Issued
NICHD E-141-2019-0-CA-03 MONOMERIC AND OLIGOMERIC COMPOUND EMBODIMENTS AS CONTRACEPTIVES AND THERAPIES AND METHODS OF MAKING AND USING THE SAME CA National Stage 3184810 Pending
NCI E-215-2018-0-US-09 2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF US CON 17/343,350 11254662 Issued PDF
NCI E-118-2021-0-US-01 CROSS SPECIES SINGLE DOMAIN ANTIBODIES TARGETING PD-L1 FOR TREATING SOLID TUMORS US 63/208,755 Abandoned
NCI E-148-2021-0-US-01 COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER US 63/208,719 Abandoned
NCI E-106-2021-0-US-01 SMALL MOLECULES TARGETING A NONCANONICAL, HAIRPIN-CONTAINING G-QUADRUPLEX STRUCTURE IN MYCN GENE US 63/208,918 Abandoned
NCI E-078-2020-0-CA-04 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM CA National Stage 3186654 Pending
NCI E-078-2020-0-PCT-02 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM PCT PCT PCT/US2021/036548 Expired
NCI E-078-2020-0-AU-03 SIZE-DEPENDENT BRAIN AND LYMPHATIC DISTRIBUTION OF MACROMOLECULAR DRUG DELIVERY PLATFORM AU National Stage 2021289443 Pending
NCI E-230-2012-0-AU-63 T Cell Receptors Recognizing MHC Class II-Restricted Mage-A3 AU DIV 2021203746 Issued
NEI E-044-2018-0-US-03 EXOSOMES AND MIRNA TO TREAT GLAUCOMA US DIV 17/341,057 11806369 Issued PDF
NCATS E-198-2016-0-US-08 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling US CON 17/340,589 11654147 Issued PDF
NIAID E-143-2018-0-PCT-02 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS PCT PCT PCT/US2021/036030 Expired
NIAID E-143-2018-0-US-02 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS US National Stage 18/008,393 Pending
NIDDK E-022-2019-0-US-03 A1 ADENOSINE RECEPTOR AGONISTS AND METHODS OF USE THEREOF US National Stage 17/299,890 Pending
NIAID E-143-2018-0-CN-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS CN National Stage 202180058491.3 Pending
NIAID E-143-2018-0-EP-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS EP National Stage 21736442.1 Pending
NIAID E-143-2018-0-HK-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS HK EP 62023071471.4 Pending
NIAID E-143-2018-0-JP-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS JP National Stage 2022-574455 Pending
NIAID E-143-2018-0-KR-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS KR National Stage 10-2023-7000585 Pending
NIAID E-143-2018-0-RU-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS RU National Stage 2022135077 Pending
NIAID E-143-2018-0-AU-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS AU National Stage 2021285997 Pending
NIAID E-143-2018-0-BR-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS BR National Stage BR112022024539-4 Pending
NIAID E-143-2018-0-MX-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS MX National Stage MX/a/2022/015398 Pending
NIAID E-143-2018-0-IN-01 LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS IN National Stage 202217074567 Pending
NIAID E-214-2021-1-US-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides US 63/197,092 Abandoned
NHLBI E-342-2013-0-US-07 Human IPSC-derived Vascular-related And Hematopoetic Cells For Therapies And Toxicology/drug Screenings US CON 17/337,978 12071634 Issued PDF